Search by Drug Name or NDC

    NDC 61958-3002-01 Sunlenca Details

    Sunlenca

    Sunlenca is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Gilead Sciences. The primary component is .

    Product Information

    NDC 61958-3002
    Product ID 61958-3002_bd4fa706-84af-4011-a69d-663fc0a3bf6b
    Associated GPIs
    GCN Sequence Number 084227
    GCN Sequence Number Description lenacapavir sodium VIAL 463.5/1.5 SUBCUT
    HIC3 W0N
    HIC3 Description ANTIRETROVIRAL - CAPSID INHIBITORS
    GCN 53433
    HICL Sequence Number 048555
    HICL Sequence Number Description LENACAPAVIR SODIUM
    Brand/Generic Brand
    Proprietary Name Sunlenca
    Proprietary Name Suffix n/a
    Non-Proprietary Name LENACAPAVIR SODIUM
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name Gilead Sciences
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA215973
    Listing Certified Through 2024-12-31

    Package

    NDC 61958-3002-01 (61958300201)

    NDC Package Code 61958-3002-1
    Billing NDC 61958300201
    Package 1 KIT in 1 CARTON (61958-3002-1) * 1.5 mL in 1 VIAL (61958-3004-1)
    Marketing Start Date 2022-12-22
    NDC Exclude Flag N
    Pricing Information N/A